Thomas J. Riordan, Director at BALDWIN MONTROSE CHEMICAL CO INC RESTRIC (SCX), bought 1,166 shares at $5.54 ($6K) on 2019-09-05, disclosed to the SEC on 2019-09-25.
Open-market purchase of $6k SCX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| SCX | BUY | 2019-12-12 | $5K | — | Filing → |
| SCX | BUY | 2018-12-14 | $4K | — | Filing → |
| SCX | BUY | 2018-03-14 | $42K | — | Filing → |